Equities

HUTCHMED (China) Ltd

HCM:LSE

HUTCHMED (China) Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)214.00
  • Today's Change-4.00 / -1.83%
  • Shares traded5.07k
  • 1 Year change-5.52%
  • Beta1.2595
Data delayed at least 20 minutes, as of Feb 06 2026 16:28 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments836886632
Total Receivables, Net172153129
Total Inventory505057
Prepaid expenses7.927.1122
Other current assets, total------
Total current assets1,0671,097840
Property, plant & equipment, net9710485
Goodwill, net------
Intangibles, net------
Long term investments834874
Note receivable - long term------
Other long term assets151516
Total assets1,2741,2801,029
LIABILITIES
Accounts payable433671
Accrued expenses228255246
Notes payable/short-term debt23310
Current portion long-term debt/capital leases2.933.930
Other current liabilities, total797737
Total current liabilities377403354
Total long term debt645123
Total debt908623
Deferred income tax2.991.482.71
Minority interest121327
Other liabilities, total598113
Total liabilities514549419
SHAREHOLDERS EQUITY
Common stock878786
Additional paid-in capital1,5181,5221,497
Retained earnings (accumulated deficit)(833)(871)(971)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(12)(8.16)(1.9)
Total equity760731610
Total liabilities & shareholders' equity1,2741,2801,029
Total common shares outstanding872871865
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.